SOTAC PHARMACEUTICALS
Back to Cashflow Statement
|
SOTAC PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹-4.33 Cr | ₹-16 Cr | ₹8.14 Cr | ₹6.35 Cr | ₹-0.31 Cr |
What is the latest Cash Flow from Operating Activities ratio of SOTAC PHARMACEUTICALS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹-4.33 Cr |
| Mar2024 | ₹-16 Cr |
| Mar2023 | ₹8.14 Cr |
| Mar2022 | ₹6.35 Cr |
| Mar2021 | ₹-0.31 Cr |
How is Cash Flow from Operating Activities of SOTAC PHARMACEUTICALS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-4.33 Cr | Negative | |
| Mar2024 | ₹-16 Cr | Negative | |
| Mar2023 | ₹8.14 Cr | 28.22 | |
| Mar2022 | ₹6.35 Cr | Positive | |
| Mar2021 | ₹-0.31 Cr | - | |
Compare Cash Flow from Operating Activities of peers of SOTAC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SOTAC PHARMACEUTICALS | ₹100.0 Cr | -0.4% | -15.1% | -21% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,280.0 Cr | -2.4% | -6.2% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,737.0 Cr | -3.3% | 1.4% | 57.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,129.0 Cr | -4.5% | -4% | 35.9% | Stock Analytics | |
| CIPLA | ₹108,808.0 Cr | -3.6% | -5% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,170.0 Cr | -0.2% | 2.5% | -3% | Stock Analytics | |
SOTAC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SOTAC PHARMACEUTICALS | -0.4% |
-15.1% |
-21% |
| SENSEX | -2.3% |
-6.6% |
-12% |
You may also like the below Video Courses